Browse

Oral Presentation Abstracts

AHNS032

CHRONIC OPIOID USE IN PATIENTS WITH OROPHARYNGEAL SQUAMOUS CELL CARCINOMA TREATED WITH RADIOTHERAPY

Survivorship

Justin Dourado, Kathryn Hitchcock, MD, PhD, Peter Dziegielewski, MD, Brian Boyce, MD, Amy Fullerton, SLP, Kristianna Fredenburg, MD, PhD, Priya Gopalan, MD, PhD, Chris Morris, MS, Patrick Tighe, MD, MS, Roger Fillingim, PhD, Natalie Silver, MD, MS

University of Florida


AHNS033

IMPACT OF PATIENT SYMPTOMS ON CAREGIVER TASK BURDEN IN LOCALLY ADVANCED HEAD AND NECK CANCER

Survivorship

Emily H Castellanos, MD1, Mary Dietrich, PhD2, Stewart M Bond, PhD, RN, AOCN3, Karen Schumacher, PhD, RN4, Nancy Wells, DNSc, RN, FAAN2, Barbara A Murphy, MD1

1Vanderbilt University Medical Center, 2Vanderbilt University School of Nursing, 3Boston College Connell School of Nursing, 4University of Nebraska Medical Center


AHNS034

RISK OF DEVELOPING NEW HEALTH DISORDERS FOLLOWING HEAD AND NECK CANCER TREATMENT VARIES SIGNIFICANTLY BY HEAD AND NECK CANCER SUBSITE: AN ANALYSIS OF THE UTAH HEAD AND NECK CANCER SURVIVOR’S STUDY

Survivorship

Marcus M Monroe, MD1, Sarah Abdelaziz1, Jason Hunt1, Luke Buchmann1, Richard Cannon1, Kerry Rowe2, Shane Lloyd1, Donald Cannon1, Ying Hitchcock1, John Snyder2, Yuan Wan1, Vikrant Deshmukh1, Michael Newman1, Alison Fraser1, Ken Smith1, Kim Herget1, Mia Hashibe, PhD1

1University of Utah, 2Intermountain Healthcare, Salt Lake City


AHNS035

RACIAL DISPARITIES AND HPV STATUS IN OROPHARYNGEAL CANCER

Survivorship

Nicholas Lenze, BS1, Douglas R Farquhar, MD, MPH1, Angela L Mazul, PhD, MPH2, Maheer M Masood, BA1, Jose P Zevallos, MD, MPH3

1Department of Otolaryngology/Head and Neck Surgery, University of North Carolina at Chapel Hill School of Medicine, 2Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, 3Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine in St. Louis


AHNS036

GEOGRAPHIC DISTANCE TO TREATMENT IS NOT ASSOCIATED WITH OVERALL SURVIVAL

Survivorship

1, Douglas Farquhar1, Angela Mazul1, Philip McDaniel1, Trevor Hackman1, Jose Zevallos2, Andrew Olshan1

1University of North Carolina, 2Washington University at St. Louis


AHNS037

NECK DISABILITY AND HEALTH-RELATED QUALITY OF LIFE AMONG HEAD AND NECK CANCER SURVIVORS FOLLOWING SURGICAL AND NON-SURGICAL TREATMENT

Survivorship

Marci L Nilsen, PhD, RN1, Leila J Mady, MD, PhD, MPH2, Susan E George, PT, DPT, , MS3, Debra Pickford, BSN, RN4, Jonas T Johnson, MD, FACS2

1University of Pittsburgh, School of Nursing, 2University of Pittsburgh, School of Medicine, 3UPMC Centers for Rehab Services, 4UPMC Department of Otolaryngology


AHNS038

SYMPTOM BURDEN ASSOCIATED WITH LATE LOWER CRANIAL NEUROPATHY IN LONG-TERM OROPHARYNGEAL CANCER SURVIVORS

Oral Cancer

Puja Aggarwal, BDS, MPH, Jhankruti S Zaveri, MPH, Ryan P Goepfert, MD, G. Brandon Gunn, MD, Stephen Y Lai, MD, PhD, Clifton D Fuller, MD, PhD, Ehab Y Hanna, MD, David I Rosenthal, MD, Jan S Lewin, PhD, Katherine A Hutcheson, PhD

The University of Texas MD Anderson Cancer Center


AHNS039

THE IMPACT OF IMMUNOSUPPRESSION ON HEAD & NECK CUTANEOUS SQUAMOUS CELL CARCINOMA PROGNOSIS: A SYSTEMATIC REVIEW OF THE LITERATURE WITH META-ANALYSIS

Skin Cancer

Alhasan N Elghouche, MD, MS, Zachary E Pflum, MD, Cecelia E Schmalbach, MD, MS, FACS

Indiana University School of Medicine, Department of Otolaryngology - Head & Neck Surgery


AHNS040


AHNS041

ONCOLOGIC OUTCOMES FOLLOWING PRIMARY SURGICAL THERAPY FOR ADVANCED BASAL CELL CARCINOMA OF THE HEAD AND NECK

Skin Cancer

Amarbir S Gill, MD, Vinay R Nittur, BS, Michael Moore, MD, D. Gregory Farwell, MD, Arnaud F Bewley, MD

University of California, Davis